Partially protective effect of amantadine in the MPTP model of Parkinson's disease.

Suppr

超能文献

作者信息

Rojas P, Altagracia M, Kravsov J, Rios C

机构信息

Instituto Nacional de Neurologia y Neurocirugia, Manuel Velasco Suárez, SSA, Laboratorio de Neuroquimica, México, D.F.

出版信息

Proc West Pharmacol Soc. 1992;35:33-5.

PMID:1502234

Abstract

摘要

相似文献

Partially protective effect of amantadine in the MPTP model of Parkinson's disease.

Proc West Pharmacol Soc. 1992;35:33-5.

Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.金刚烷胺可增强帕金森病MPTP模型中的多巴胺和5-羟色胺代谢。

Proc West Pharmacol Soc. 1993;36:289-91.

[Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].

Biull Eksp Biol Med. 1999 May;127(5):502-5.

Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）诱导的帕金森病小鼠纹状体的胺荧光组织化学研究

Res Commun Chem Pathol Pharmacol. 1988 Jan;59(1):121-8.

Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.粒细胞-巨噬细胞集落刺激因子可促进1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的小鼠帕金森病模型中多巴胺能神经元的存活。

Eur J Neurosci. 2009 Mar;29(5):891-900. doi: 10.1111/j.1460-9568.2009.06653.x. Epub 2009 Feb 24.

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.神经黑色素参与1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）诱导的神经毒性的证据。

Nature. 1987;327(6120):324-6. doi: 10.1038/327324a0.

Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.

Adv Neurol. 1987;45:179-82.

The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.1-甲基-4-苯基-1,2,3,6-四氢吡啶在动物体内作为帕金森病模型的作用。

J Neural Transm Suppl. 1986;20:11-39.

Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.血管紧张素转换酶抑制剂培哚普利对MPTP处理小鼠中间神经元的影响。

Eur Neuropsychopharmacol. 2005 Jan;15(1):57-67. doi: 10.1016/j.euroneuro.2004.05.007.

Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.

J Neural Transm Suppl. 1990;32:269-75. doi: 10.1007/978-3-7091-9113-2_37.

引用本文的文献

Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?用于中枢神经系统疾病和损伤临床试验的抗炎和神经保护药物：我们将何去何从？

Front Immunol. 2020 Sep 10;11:2021. doi: 10.3389/fimmu.2020.02021. eCollection 2020.

Neuroprotection in Parkinson's disease: facts and hopes.帕金森病的神经保护：现状与展望。

J Neural Transm (Vienna). 2020 May;127(5):821-829. doi: 10.1007/s00702-019-02115-8. Epub 2019 Dec 11.

Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected].金刚烷胺通过双重作用来保护多巴胺神经元：减少小胶质细胞的激活，并诱导星形胶质细胞中 GDNF 的表达[更正]。

Neuropharmacology. 2011 Sep;61(4):574-82. doi: 10.1016/j.neuropharm.2011.04.030. Epub 2011 May 11.

Neuroprotective strategies in Parkinson's disease : an update on progress.帕金森病的神经保护策略：进展更新

CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验